Wednesday, Oct 23, 2024 · SEC filings
What the smart money revealed on Oct 23
167 insider filings came in. We hid 41 planned (10b5-1) sellers and 76 people whose filings were routine, like grants and tax withholding.
3 insiders at Inhibikase Therapeutics (IKT) bought $2.7M of stock
Roles: Director. Several insiders buying in the same few days is rare.
Texas Capital Bancshares (TCBI) Director Robert Stallings bought $426K
20,000 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.
RDE (GIFT) CTO Balazs Wellisch bought $53.7K
Open-market buys of more than one share class. Not a grant or an option exercise.
Kinder Morgan (KMI) Director C. Park Shaper sold $22.3M
Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 13.31M shares.
Cencora (COR) Executive Chairman Steven Collis sold $5.07M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 285,088 shares directly.
Plumas Bancorp (PLBC) EVP and CCO Jeffrey Moore sold $179K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 7 more real buys
Show 21 more real sales
13F season
Holdings as of Sep 30, 2024 are due Nov 14
58 funds have filed so far. 54 filed for the quarter before.
Biggest real insider buys, Oct 17–23
Open-market buys by officers and directors, filed in the 7 days up to Oct 23.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.